increased B cell derived lymphoma incidence_Tg(Igh*-Mir125b-1)5Toki/0

http://metadb.riken.jp/0002023NSTgIghMir125b15Toki0TgIghMir125b15Toki

increased B cell derived lymphoma incidence_Tg(Igh*-Mir125b-1)5Toki/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 5, Toshio Kitamura
  http://metadb.riken.jp/db/mgi_rdf/MGI:5317562

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Igh*-Mir125b-1)5Toki/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Igh*-Mir125b-1)5Toki

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• Not Specified

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased B cell derived lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0002023

文献

http://purl.org/net/cito/citesAsAuthority

• Y. Enomoto, et.al., Eμ/miR-125b transgenic mice develop lethal B-cell malignancies., Leukemia, 2011, 25
  http://rdf.ncbi.nlm.nih.gov/pubmed/21738213